🇺🇸 FDA
Patent

US 10087210

Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

granted A61PA61P31/12A61P35/00

Quick answer

US patent 10087210 (Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/12, A61P35/00